Michael D. Staehler
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 171
- Prostate Cancer Treatment and Research 8
-
- Cancer Genomics and Diagnostics 30
- Co-authors
- Axel Bex (26 shared papers)Börje Ljungberg (25 shared papers)Saeed Dabestani (19 shared papers)Thomas B. L. Lam (19 shared papers)Lorenzo SO Marconi (18 shared papers)Fabian Hofmann (15 shared papers)Karim Bensalah (19 shared papers)Alessandro Volpe (18 shared papers)
- Journals
- European Urology (24 papers)Annals of Oncology (16 papers)Clinical Genitourinary Cancer (11 papers)The Journal of Urology (11 papers)British Journal of Urology (9 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Michael D. Staehler
239 papers receiving 16.5k citations
Michael D. Staehler's Hit Papers
Peers
Comparison fields: 5 of 144
- Pulmonary and Respiratory Medicine 10.6k
- Cancer Research 2.6k
- Oncology 2.9k
- Molecular Biology 4.7k
- Radiology, Nuclear Medicine and Imaging 1.2k
Countries citing papers authored by Michael D. Staehler
This map shows the geographic impact of Michael D. Staehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Staehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Staehler more than expected).
Fields of papers citing papers by Michael D. Staehler
This network shows the impact of papers produced by Michael D. Staehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Staehler. The network helps show where Michael D. Staehler may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael D. Staehler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 253 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EAU Guidelines on Renal Cell Carcinoma: 2014 Update Hit paper breakdown → | 2015 | 2278 |
| 2 | Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 2013 | 1579 |
| 3 | European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update Hit paper breakdown → | 2019 | 1113 |
| 4 | Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial Hit paper breakdown → | 2009 | 934 |
| 5 | Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial Hit paper breakdown → | 2019 | 817 |
| 6 | Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Hit paper breakdown → | 2012 | 680 |
| 7 | Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy Hit paper breakdown → | 2016 | 592 |
| 8 | Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy Hit paper breakdown → | 2015 | 432 |
| 9 | Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2009 | 406 |
| 10 | 2009 | 351 | |
| 11 | 2008 | 297 | |
| 12 | 2014 | 244 | |
| 13 | 2010 | 192 | |
| 14 | 2019 | 178 | |
| 15 | 2017 | 166 | |
| 16 | 2013 | 161 | |
| 17 | 2011 | 142 | |
| 18 | 2017 | 137 | |
| 19 | 2016 | 127 | |
| 20 | 2008 | 122 |
About Michael D. Staehler
Michael D. Staehler is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Surgery and Molecular Biology, having authored 253 papers that have together received 16.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (171 papers), Renal and related cancers (50 papers), Cancer Genomics and Diagnostics (30 papers), Bladder and Urothelial Cancer Treatments (26 papers), Cancer Immunotherapy and Biomarkers (13 papers), MRI in cancer diagnosis (9 papers), Advanced X-ray and CT Imaging (9 papers) and Prostate Cancer Treatment and Research (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.6k citations), Cancer Research (2.6k citations), Oncology (2.9k citations), Molecular Biology (4.7k citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Michael D. Staehler has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Axel Bex, Börje Ljungberg, Saeed Dabestani, Thomas B. L. Lam, Lorenzo SO Marconi, Fabian Hofmann, Karim Bensalah, Alessandro Volpe, Markus Antonius Kuczyk and Milan Hora. Their work appears in journals such as European Urology, Annals of Oncology, Clinical Genitourinary Cancer, The Journal of Urology and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.